NASDAQ:MEDP • US58506Q1094
Taking everything into account, MEDP scores 7 out of 10 in our fundamental rating. MEDP was compared to 58 industry peers in the Life Sciences Tools & Services industry. MEDP gets an excellent profitability rating and is at the same time showing great financial health properties. MEDP is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make MEDP suitable for growth and quality investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROIC | 71.19% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 6.52 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 26.43 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.35 | ||
| EV/EBITDA | 21.03 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:MEDP (2/26/2026, 2:06:02 PM)
444.27
+6.19 (+1.41%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.04 | ||
| Fwd PE | 26.43 | ||
| P/S | 4.95 | ||
| P/FCF | 18.35 | ||
| P/OCF | 17.55 | ||
| P/B | 27.26 | ||
| P/tB | N/A | ||
| EV/EBITDA | 21.03 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 22.84% | ||
| ROE | 98.27% | ||
| ROCE | 84.68% | ||
| ROIC | 71.19% | ||
| ROICexc | 333.94% | ||
| ROICexgc | N/A | ||
| OM | 21.14% | ||
| PM (TTM) | 17.83% | ||
| GM | 30.06% | ||
| FCFM | 26.95% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.49% | ||
| Cap/Sales | 1.24% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 126.67% | ||
| Profit Quality | 151.15% | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.74 | ||
| Altman-Z | 6.52 |
ChartMill assigns a fundamental rating of 7 / 10 to MEDP.
ChartMill assigns a valuation rating of 5 / 10 to MEDPACE HOLDINGS INC (MEDP). This can be considered as Fairly Valued.
MEDPACE HOLDINGS INC (MEDP) has a profitability rating of 9 / 10.
The Price/Earnings (PE) ratio for MEDPACE HOLDINGS INC (MEDP) is 29.04 and the Price/Book (PB) ratio is 27.26.
The financial health rating of MEDPACE HOLDINGS INC (MEDP) is 8 / 10.